[Chronic autoimmune thyroiditis in the child]

Arch Pediatr. 2000 Dec;7(12):1284-92. doi: 10.1016/s0929-693x(00)00144-5.
[Article in French]

Abstract

Objective: The aim of the study was to describe the clinical characteristics and long-term follow-up of a group of children with chronic autoimmune thyroiditis.

Patients and methods: Sixty children (age: 11.9 +/- 2.7 years) were studied in a retrospective analysis.

Results: At diagnosis, 34 of the children were hypothyroid (compensated hypothyroidism, n = 15; true hypothyroidism, n = 19) and 26 euthyroid. Thyroid ultrasonography showed characteristic features of heterogenicity and/or hypoechogenicity in all patients. Other autoimmune diseases were found in ten subjects (17%) and 23% had a family history of thyroid disease. At the end of the follow-up, nine of 45 children (20% of the cases) followed up for at least one year (mean follow-up 4.4 +/- 3.7 years), demonstrated a change in thyroid function. Hypothyroidism was detected in two initially euthyroid patients. Among initially hypothyroid patients, seven (28%) recovered normal thyroid function, allowing L-thyroxine withdrawal for four weeks, after 1.5 to 8.4 years. No factor was found to be predictive of the course of the disease. All subjects treated with L-thyroxine for hypothyroidism reached normal final height.

Conclusion: The natural course of chronic lymphocytic thyroiditis is variable and unpredictable. Recovery from hypothyroidism does occur and can be aided by the L-thyroxine withdrawal test. The disease requires lifelong thyroid surveillance, especially in women during pregnancy, in order to avoid a potential adverse effect on the future child.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Hypothyroidism / drug therapy
  • Hypothyroidism / etiology
  • Hypothyroidism / pathology
  • Male
  • Pregnancy
  • Pregnancy Complications / prevention & control
  • Prognosis
  • Retrospective Studies
  • Thyroiditis, Autoimmune / pathology*
  • Thyroxine / therapeutic use*

Substances

  • Thyroxine